000590.SZ Stock Analysis
00
Avoid
Based on Eyestock quantitative analysis, 000590.SZ`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
Tus-Pharmaceutical Group Co., Ltd. engages in the research and development, production and sales of Chinese patent medicine. The company is headquartered in Hengyang, Hunan and currently employs 1,214 full-time employees. The firm provides Chinese medicines, including Chinese healthcare products, medicines for cold treatment and anti hyperlipemia medicines, among others. The company also provides western medicine preparations, including clindamycin phosphate for injection, lomefloxacin hydrochloride for injection and levofloxacin lactate for injection, among others. The firm distributes its products in domestic markets.